Toward antibody-directed “abzyme” prodrug therapy, ADAPT: Carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing.

WENTWORTH P; DATTA A; BLAKEY D; BOYLE T; PARTRIDGE L J; BLACKBURN G M

Art

J-GLOBAL ID：200902122357749050 Reference number：96A0266544

Toward antibody-directed “abzyme” prodrug therapy, ADAPT: Carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing.

抗体特異酵素‘abzyme’をプロドラッグとして用いる治療,ADAPT 抗体酵素によるカルバメートプロドラッグの活性化とin vitroでのヒト癌細胞死滅への適用

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=96A0266544&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=96A0266544&from=J-GLOBAL&jstjournalNo=D0387A") }}

Author (6)： , , , , ,
Material：
Volume： 93 Issue： 2 Page： 799-803 Publication year： Jan. 23, 1996
JST Material Number： D0387A ISSN： 0027-8424 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=96A0266544&from=J-GLOBAL&jstjournalNo=D0387A") }}

Basic research of antitumor(=antineoplastic)drugs

, , , , , , , ,

Return to Previous Page